metoprolol has been researched along with Edema, Pulmonary in 4 studies
Metoprolol: A selective adrenergic beta-1 blocking agent that is commonly used to treat ANGINA PECTORIS; HYPERTENSION; and CARDIAC ARRHYTHMIAS.
metoprolol : A propanolamine that is 1-(propan-2-ylamino)propan-2-ol substituted by a 4-(2-methoxyethyl)phenoxy group at position 1.
Excerpt | Relevance | Reference |
---|---|---|
" More importantly, ruboxistaurin prevented death in wild-type mice throughout 10 weeks of pressure-overload stimulation, reduced ventricular dilation, enhanced ventricular performance, reduced fibrosis, and reduced pulmonary edema comparable to or better than metoprolol treatment." | 7.75 | Protein kinase C{alpha}, but not PKC{beta} or PKC{gamma}, regulates contractility and heart failure susceptibility: implications for ruboxistaurin as a novel therapeutic approach. ( Chen, X; Houser, SR; Kranias, EG; Leitges, M; Liu, Q; Lorenz, JN; Macdonnell, SM; Molkentin, JD, 2009) |
" More importantly, ruboxistaurin prevented death in wild-type mice throughout 10 weeks of pressure-overload stimulation, reduced ventricular dilation, enhanced ventricular performance, reduced fibrosis, and reduced pulmonary edema comparable to or better than metoprolol treatment." | 3.75 | Protein kinase C{alpha}, but not PKC{beta} or PKC{gamma}, regulates contractility and heart failure susceptibility: implications for ruboxistaurin as a novel therapeutic approach. ( Chen, X; Houser, SR; Kranias, EG; Leitges, M; Liu, Q; Lorenz, JN; Macdonnell, SM; Molkentin, JD, 2009) |
"Mortality, pulmonary edema, and need for IABP were reduced by >50% (p < 0." | 1.32 | Impact of prophylactic postoperative beta-blockade on post-cardiothoracic surgery length of stay and atrial fibrillation. ( Coleman, CI; Gallagher, R; Gillespie, EL; Horowitz, S; Kluger, J; Perkerson, KA; White, CM, 2004) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Liu, Q | 1 |
Chen, X | 1 |
Macdonnell, SM | 1 |
Kranias, EG | 1 |
Lorenz, JN | 1 |
Leitges, M | 1 |
Houser, SR | 1 |
Molkentin, JD | 1 |
Coleman, CI | 1 |
Perkerson, KA | 1 |
Gillespie, EL | 1 |
Kluger, J | 1 |
Gallagher, R | 1 |
Horowitz, S | 1 |
White, CM | 1 |
Kuhn, U | 1 |
Kuhn, W | 1 |
Grospietsch, G | 1 |
Engelmann, A | 1 |
Girndt, J | 1 |
Strigl, R | 1 |
Pfeiffer, U | 1 |
Aschenbrenner, G | 1 |
Blümel, G | 1 |
4 other studies available for metoprolol and Edema, Pulmonary
Article | Year |
---|---|
Protein kinase C{alpha}, but not PKC{beta} or PKC{gamma}, regulates contractility and heart failure susceptibility: implications for ruboxistaurin as a novel therapeutic approach.
Topics: Adrenergic beta-Antagonists; Animals; Calcium Signaling; Cardiomegaly; Disease Models, Animal; Fibro | 2009 |
Impact of prophylactic postoperative beta-blockade on post-cardiothoracic surgery length of stay and atrial fibrillation.
Topics: Adrenergic beta-Antagonists; Aged; Atenolol; Atrial Fibrillation; Cardiac Surgical Procedures; Cohor | 2004 |
[The effect of metoprolol on fenoterol-induced kidney function disorders].
Topics: Animals; Creatinine; Electrolytes; Ethanolamines; Female; Fenoterol; Hematocrit; Hemoglobins; Kidney | 1983 |
Influence of the beta-1 selective blocker, metoprolol, on the development of pulmonary edema in tocolytic therapy.
Topics: Animals; Blood Pressure; Capillary Permeability; Cardiac Output; Dogs; Female; Fenoterol; Heart Rate | 1986 |